TRANSGENE BIOTEK LTD. | Scrip Code : 526139 | Quarter ending :December 2017 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | No | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 3 | 1,64,27,902 | 1,64,27,902 | 23.64 | 1,64,27,902 | 21.68 | 64,27,902 | - | - | - | (B) Public | 10,716 | 5,30,72,098 | 5,30,72,098 | 76.36 | 5,30,72,098 | 70.04 | 5,25,96,524 | - | - | - | (C1) Shares underlying DRs | 1 | 62,70,000 | 62,70,000 | 0.00 | 62,70,000 | 8.28 | 62,70,000 | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | 1 | 62,70,000 | 62,70,000 | 0.00 | 62,70,000 | 8.28 | 62,70,000 | - | - | - | Grand Total | 10,720 | 7,57,70,000 | 7,57,70,000 | 100.00 | 7,57,70,000 | 100.00 | 6,52,94,426 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|